Exchange: NYSEArca·Updated 01:22 PM EDT
NVOX logo

NVOXDefiance Daily Target 2X Long NVO ETF

$18.42
$0.7186
(4.06%)
Today
Vol245,327.00
52W High$54.08
52W Low$9.23
News
all
press releases
News Placeholder
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Stocktwits
<
...
1
>

Advertisement|Remove ads.